Citation Impact
Citing Papers
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
2009 StandoutScience
Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study
2000
The Epidemiology of Major Depressive Disorder
2003 Standout
Regional HmPAO SPECT and CT Measurements in the Diagnosis of Alzheimer's Disease
1997
Are impulse-control disorders related to bipolar disorder?
1996
Mitochondrial Dysfunction in Neurodegeneration
1997
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
The cholinergic hypothesis of Alzheimer's disease: a review of progress
1999 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Management of acute organophosphorus pesticide poisoning
2007 Standout
Sjögren's syndrome
2005 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
2004
The Cholinergic Hypothesis of Neuropsychiatric Symptoms in Alzheimer's Disease
1998
Peripheral glucose administration stimulates the translocation of GLUT8 glucose transporter to the endoplasmic reticulum in the rat hippocampus
2002
Schizophrenia
2009 Standout
Cerebral blood flow and metabolic abnormalities in Alzheimer’s disease
2001
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer’s Disease Treatment Studies
2002
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
1992
Influence of context effects on health outcomes: a systematic review
2001 Standout
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects
1998
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
2002 Standout
Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4
1996 Standout
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Triptans in Migraine
2000
Interpretation Variability of 18FDG-Positron Emission Tomography Studies in Dementia
1996
Placebo‐associated improvements in motor function: Comparison of subjective and objective sections of the UPDRS in early Parkinson's disease
2002
Guidelines for Controlled Trials of Drugs in Migraine: Second Edition
2000
The facilitative glucose transporter GLUT3: 20 years of distinction
2008
Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment
2001
Neuropathological stageing of Alzheimer-related changes
1991 Standout
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI
2019 StandoutNobel
Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease
1990
Positron emission tomography study of human brain functional development
1987 Standout
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
2004 Standout
Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo
2004 Standout
Mitochondrial control of cell death
2000 Standout
SECOND DOROTHY S. RUSSELL MEMORIAL LECTURE THE NEUROPATHOLOGY OF ALZHEIMER'S DISEASE–ISSUES IN NEED OF RESOLUTION*
1989
Parkinson's disease
2015 Standout
5‐HT1receptors in migraine pathophysiology and treatment
1995
Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study
1999
Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease
1997
Age-Related Regional Network of Magnetic Resonance Imaging Gray Matter in the Rhesus Macaque
2008
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
2003 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Migraine — Current Understanding and Treatment
2002 Standout
Alzheimer's disease
2006 Standout
Copper-Dependent Inhibition of Human CytochromecOxidase by a Dimeric Conformer of Amyloid-β1-42
2005
Clinical evaluation of pramipexole in advanced Parkinson's disease: Results of a double-blind, placebo-controlled, parallel-group study
1997
Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos
2000
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders
2009
Central neurocircuitry associated with emesis
2001
Alzheimer's Disease
2010 Standout
GLUT-1 Expression in the Cerebra of Patients with Alzheimer’s Disease
1997
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
2006 StandoutNature
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
2004 Standout
Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET
1999
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
Generalized Anxiety Disorder
2004
Alzheimer's Disease
2004 Standout
Structure and dynamics of the M3 muscarinic acetylcholine receptor
2012 StandoutNatureNobel
Cholinesterase Inhibitors for Alzheimer??s Disease
2001
Hippocampal formation glucose metabolism and volume losses in MCI and AD
2001
The Brain's Default Network
2008 Standout
Serum neuron-specific enolase as early predictor of outcome after cardiac arrest
1997
Oxidative damage and mitochondrial decay in aging.
1994 Standout
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
2005 Standout
Treatment of the Neuropsychiatric Symptoms in Alzheimer's Disease
2003
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
311C90 (Zolmitriptan), A Novel Centrally and Peripheral Acting Oral 5-Hydroxytryptamine-1D Agonist: A Comparison of Its Absorption During A Migraine Attack and in A Migraine-Free Period
1996
Management of Parkinson's disease: An evidence-based review
2002
Alzheimer's disease
1998 Standout
Iofetamine I 123 Single Photon Emission Computed Tomography Is Accurate in the Diagnosis of Alzheimer's Disease
1990
The Hitchhiker’s Guide to Flow Chemistry
2017 Standout
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
2000 Standout
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
Part 9: Post–Cardiac Arrest Care
2010 Standout
Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease
1997
Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI
2004 Standout
A Brief Measure for Assessing Generalized Anxiety Disorder
2006 Standout
Positron emission tomography provides molecular imaging of biological processes
2000
Lu 25-109, a muscarinic agonist, fails to improve cognition in Alzheimer’s disease
2000
Physical Activity and Public Health in Older Adults
2007 Standout
Current and Novel Approaches to the Drug Treatment of Schizophrenia
2001
Emerging drugs for schizophrenia
2008
Positron emission tomography for diagnosis of Alzheimer’s disease and vascular dementia
1998
Muscarinic Receptor Agonists and Antagonists
2001
Muscarinic Receptor Agonists in Alzheimer??s Disease
1999
Biological Markers in Alzheimer Disease
2002
Dynamic mapping of human cortical development during childhood through early adulthood
2004 Standout
Triptans (Serotonin, 5-HT1B/1D Agonists) in Migraine: Detailed Results and Methods of A Meta-Analysis of 53 Trials
2002
A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer’s disease
1999
N-Methyl-5-tert-butyltryptamine: A Novel, Highly Potent 5-HT1D Receptor Agonist
1999
The selective muscarinic M1 agonist AF102B decreases levels of total A? in cerebrospinal fluid of patients with Alzheimer's disease
2000
Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis
1997
Works of N.R. Cutler being referenced
Pramipexole in Patients with Early Parkinsonʼs Disease
1995
Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease
1997
Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine
2001
Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan
1995
Retrospective diagnosis of hypomania following successful treatment of episodic violence with lithium: a case report
1978
Oral sumatriptan for the long-term treatment of migraine: clinical findings.
1995
Oral Sumatriptan in Pharmacokinetics in the Migrainous State
1991
Cerebrospinal Fluid Neuron-Specific Enolase Is Reduced in Alzheimer's Disease
1986
Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
1996
Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths.
1995
Pilot Study of MK-462 in Migraine
1996
Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine.
2001
Positron emission tomography in Alzheimer's disease
1986